
According to a press release, Myatro XL is the first 0.05% atropine eye drop for pediatric myopia control. It will be commercially available in India in July 2025.

According to a press release, Myatro XL is the first 0.05% atropine eye drop for pediatric myopia control. It will be commercially available in India in July 2025.

The laboratory is equipped with professional-grade technology and replicates a high-end retail optical dispensing and vision testing environment.

Vision care organizations and companies met to emphasize how tariffs are increasing the cost of eyewear and vision products.

The ONE by ONE Recycling and Biotrue Eye Care Recycling programs have collected a total of 103,169,500 units.

Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.

The report outlines views and behaviors of US adults regarding vision correction, managed vision care, eye examinations, prescription eyewear, reading glasses, and nonprescription sunglasses.

Catch up on the top stories in optometry during the week of April 14-April 18.

A survey collected demographic data, ocular and medical history, and responses assessing knowledge of glaucoma and cataracts in the Qassim region of Saudi Arabia.

Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.

Jamie Kuzniar, OD, FAAO, FSLS, has found her niche in specialty contact lenses and individualized care at her practice, Elevate Eye Care + Eyewear.

The survey results included 11,412 patients in the general population and 964 health care providers.

The affected mandate requires that all newborns receive erythromycin ointment applied to their eyes after birth, which helps prevent ophthalmia neonatorum.

The VLP system, engineered nucleocytosolic vehicle for loading of programmable editors (ENVLPE), was found to have corrected 2 mutations associated with blindness.

The program also offers eligible students with an in-school commitment to hire them after graduation and provides support for federal and private loans.

CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.

The award recognizes CooperVision for its support of educational opportunities for students, including the sponsorship of a new eye care clinic.

Rachelle Lin, OD, MS, FAAO, and Quan Đông Nguyễn, MD, MSc, lectured on retinal updates at CRU 2025. The pair also covered the power of a low vision referral for patients with retinal disease.

The first 6 patients in the study had an average improvement of 14.9 letters in early treatment diabetic retinopathy study (ETDRS) standard vision tests within 4 to 6 months post transplantation.

Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.

Catch up on the top stories in optometry during the week of April 7-April 11.

CLI Visionaries provide professional perspectives on best practices and highlight the EASY (Eyes, Awareness, Safety & You) Way program in the series.

Deborah Ristvedt, DO, and Melissa Tawa, OD, FAAO, detail the benefits of interventional glaucoma during their CRU 2025 presentation.

The Vision Council report highlights providers’ expectations and the perceived impact of economic factors including tariffs, inflation, staffing and hiring, and technological integration including telehealth and artificial intelligence.

Cecelia Koetting, OD, FAAO, DipABO, and Madeline Yung, MD, detailed the prevalence of the conditions, diagnostic tools, and treatment options.

Dr Rachelle Lin highlights the urgent need for early intervention in childhood myopia, discusses associated retinal and systemic risks, and emphasizes the long-term impact of axial length control in reducing serious ocular complications.

Rachelle Lin, OD, MS, FAAO, and Quan Đông Nguyễn, MD, MSc, presented available treatment options and what is coming down the pipeline for retinal conditions.

The expansion will allow the company to double the number of intraocular lenses manufactured every year to 4 million.

Brimochol PF’s combination of brimonidine and carbachol produces a “pinhole effect,” which is intended to improve depth of focus and sharpen near and distant impact.

The lens has been introduced to select practices across the US, with broad commercial availability planned for in May.

The novel corrective eye drop can be prescribed through pharmacy partners BlinkRx or Medvantx.